Here are six things to know:
1. The company increased its private placement to up to 10 million common shares, at CDN$0.10 per common share for gross proceeds of up to $1 million.
2. The offering will close in early February.
3. Aurora Spine believes some company directors and officers may take part in the offering.
4. The company will use the offering’s net proceeds for general working capital.
5. All issued securities with this offering will undergo a statutory four-month hold period.
6. Aurora Spine develops screwless, innovative, minimally invasive, regenerative spinal implant technologies.
More articles on devices:
Global wearable medical devices market to hit $14.4B by 2022 — 6 things to know
InVivo appoints Dr. Richard Toselli CEO: 5 things to know
Ceterix Orthopaedics completes enrollment in NovoStitch meniscal repair study: 4 things to know
